Dr. Robert Mak, MD

NPI: 1740295252
Total Payments
$5,446
2023 Payments
$124.99
Companies
4
Transactions
18

Payment Breakdown by Category

Other$3,000 (55.1%)
Food & Beverage$1,421 (26.1%)
Travel$1,023 (18.8%)
Education$2.14 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 55.1%
Food and Beverage $1,421 14 26.1%
Travel and Lodging $1,023 2 18.8%
Education $2.14 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Ultragenyx Pharmaceutical Inc. $4,616 8 $0 (2020)
Alexion Pharmaceuticals, Inc. $609.03 6 $0 (2021)
Calliditas Therapeutics US Inc. $124.99 1 $0 (2023)
OPKO Pharmaceuticals, LLC $96.23 3 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $124.99 1 Calliditas Therapeutics US Inc. ($124.99)
2021 $122.10 1 Alexion Pharmaceuticals, Inc. ($122.10)
2020 $167.37 2 Ultragenyx Pharmaceutical Inc. ($167.37)
2019 $4,449 6 Ultragenyx Pharmaceutical Inc. ($4,449)
2018 $147.73 2 Alexion Pharmaceuticals, Inc. ($120.00)
2017 $435.43 6 Alexion Pharmaceuticals, Inc. ($366.93)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/26/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Nephrology
11/09/2021 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $122.10 General
07/20/2020 Ultragenyx Pharmaceutical Inc. Cryvista (Drug) Food and Beverage In-kind items and services $149.32 General
Category: XLH Metabolic Bone Disorder
01/21/2020 Ultragenyx Pharmaceutical Inc. Cryvista (Drug) Food and Beverage In-kind items and services $18.05 General
Category: XLH Metabolic Bone Disorder
07/18/2019 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: XLH
07/18/2019 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Travel and Lodging Cash or cash equivalent $869.01 General
Category: XLH
07/18/2019 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage In-kind items and services $284.12 General
Category: XLH
07/18/2019 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Travel and Lodging Cash or cash equivalent $154.12 General
Category: XLH
07/18/2019 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage In-kind items and services $21.38 General
Category: XLH
06/13/2019 Ultragenyx Pharmaceutical Inc. CRYSVITA (Drug) Food and Beverage In-kind items and services $120.22 General
Category: XLH
10/23/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $120.00 General
Category: Immunology
02/15/2018 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $27.73 General
Category: Hyperparathyroidism
09/20/2017 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $121.21 General
Category: Immunology
05/31/2017 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $22.69 General
Category: Hyperparathyroidism
04/06/2017 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $45.81 General
Category: Hyperparathyroidism
02/23/2017 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $121.79 General
Category: Immunology
01/26/2017 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $121.79 General
Category: Immunology
01/26/2017 Alexion Pharmaceuticals, Inc. Strensiq (Drug) Education In-kind items and services $2.14 General
Category: Endocrinology

About Dr. Robert Mak, MD

Dr. Robert Mak, MD is a Pediatric Nephrology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740295252.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mak, MD has received a total of $5,446 in payments from pharmaceutical and medical device companies, with $124.99 received in 2023. These payments were reported across 18 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,000).

Practice Information

  • Specialty Pediatric Nephrology
  • Location San Diego, CA
  • Active Since 07/31/2006
  • Last Updated 10/14/2011
  • Taxonomy Code 2080P0210X
  • Entity Type Individual
  • NPI Number 1740295252

Products in Payments

  • Crysvita (Drug) $4,329
  • SOLIRIS (Drug) $484.79
  • Cryvista (Drug) $167.37
  • TARPEYO (Drug) $124.99
  • CRYSVITA (Drug) $120.22
  • Rayaldee (Drug) $96.23
  • Strensiq (Drug) $2.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Nephrology Doctors in San Diego